Core Viewpoint - UAB "Kvartalas" is preparing to launch the third tranche of bonds to finance the development of the "Sąvaržėlė" business centre, indicating strong investor interest and potential modifications to the subscription process based on demand [1][2]. Group 1 - The third tranche of bonds (ISIN LT0000411167) is aimed at financing the "Sąvaržėlė" business centre [1]. - Due to high demand for previous bond tranches, the issuer may modify the subscription process, potentially shortening the subscription period if sufficient demand is reached [2]. - The final terms of the third tranche will be announced before the subscription period opens, detailing the offering and the possibility of early closure based on demand [3].

Company Overview - Karolinska Development AB is a Nordic life sciences investment company focused on identifying breakthrough medical innovations in the Nordic region [3][4] - The company has a portfolio of eleven companies targeting innovative treatments for life-threatening or serious debilitating diseases [5] - Karolinska Development holds a 73% ownership stake in Umecrine Cognition, which is developing a new class of drugs for cognitive symptoms caused by liver disease [2] Clinical Trial Update - Umecrine Cognition has resumed patient inclusion in the clinical phase 1b/2a trial for the drug candidate golexanolone in patients with primary biliary cholangitis (PBC) [1] - The trial had been previously halted in March due to technical issues in capsule production, but this did not affect patient safety [1] Drug Development Focus - Golexanolone is being evaluated in a randomized, double-blind, placebo-controlled study aimed at patients with PBC who experience significant fatigue and cognitive symptoms [2]

Board Composition Changes - Guerbet's Annual General Meeting voted to reduce the terms of office of directors from six years to four years to comply with the Afep-Medef Code of corporate governance [2][9] - The terms of office for Claire Jouault Massiot, Céline Lamort, Mark Fouquet, Didier Izabel, and Jean-Sebastien Raynaud expired at the Annual General Meeting, and Pascale Auger resigned as a director [3][11] - Two new directors were appointed, Michèle Lesieur and Eric Drapé, while Céline Lamort and Marc Massiot were re-elected, bringing the total number of directors to nine [3][10][11] New Appointments - Michèle Lesieur was appointed as an independent director for a three-year term, bringing extensive experience in the healthcare sector, including leadership roles at Philips and Supersonic Imagine [4][5] - Eric Drapé was appointed as an independent director for a four-year term, with over 35 years of experience in the pharmaceutical industry, including senior positions at Teva Pharmaceuticals and Ipsen Pharma [6][7] Board Structure - The current Board of Directors consists of nine members, including three independent directors: Hugues Lecat, Eric Drapé, and Michèle Lesieur [11][12] - The Board expressed gratitude to outgoing directors for their contributions and welcomed the new appointees [11] Company Overview - Guerbet is a leader in medical imaging, offering a range of pharmaceutical products, medical devices, and digital solutions, with a revenue of €841 million in 2024 [13] - The company invests 9% of its sales in research and development across four centers in France and the United States [13]

Core Insights - Capgemini has expanded its strategic partnership with Mistral AI and SAP to provide secure, scalable generative AI solutions for regulated industries, aiming to enhance operational efficiency and business outcomes [1][5][7] - The collaboration focuses on creating a trusted environment for deploying custom AI solutions, particularly for sectors with stringent data requirements such as financial services, public sector, aerospace & defense, and energy & utilities [1][2][4] Industry Trends - Enterprises are increasingly adopting business AI to optimize processes and decision-making, with generative AI driving significant business value and competitive advantage [2] - Organizations in regulated industries face challenges in accessing AI benefits, necessitating advanced generative AI models that function within secure environments like the SAP Business Technology Platform [2] Collaboration Details - Capgemini will provide over 50 pre-built custom business AI use cases, validated by SAP and leveraging Mistral AI models, categorized by industry and process [3][4] - The collaboration emphasizes responsible and ethical AI design, ensuring data security and regulatory compliance while fostering innovation [3][4] Use Cases - Specific use cases include augmented field workers in aerospace and defense, drone-based inspections for predictive maintenance in energy and utilities, and intelligent indirect purchasing across various industries [6] Recognition and Achievements - Capgemini received the 2025 SAP Pinnacle Award for Business AI Innovation in the Customer AI use case category, highlighting its leadership in delivering AI-powered solutions [9]

Core Insights - Casino Group and H&S Invest Holding have signed a strategic partnership to open over 210 Franprix and Monoprix stores in Morocco by 2035, marking a significant step in Casino Group's international expansion strategy through franchising [2][5] - The partnership aims to enhance Morocco's convenience retail landscape by introducing innovative retail concepts that combine quality food products, fast food, everyday services, and a digitalized customer experience [3][4] - The first stores are set to open in 2026, focusing on quality, convenience, and a high proportion of local products [4] Company Overview - Casino Group is a leader in the French retail market, operating approximately 7,500 convenience stores and generating a gross merchandise volume of €12.4 billion in 2024 [7] - The Group has a presence in over 30 countries with 472 franchised stores outside Metropolitan France, contributing to 3.5% of its net sales in 2024 [2] - H&S Invest Holding, established in 2005, operates in essential sectors such as manufacturing, logistics, and retail, aiming to create over 1,000 direct and indirect jobs in Morocco by 2030 through this partnership [6]

Group 1 - CIC Lyonnaise de Banque has announced the early redemption of its "Titres Participatifs" Variable Rate Notes issued on May 28, 1985, exercising its right under the Issuer Call Option [2][3] - The early redemption date is set for June 30, 2025, with an optional redemption amount of EUR 300.68 per denomination, excluding accrued interest [4] - The issuer has instructed the Fiscal Agent to authorize the French Central Securities Depository to cancel the redeemed notes on the specified early redemption date [4] Group 2 - CIC Lyonnaise de Banque operates as a leading bank in the South-Eastern region of France, with nearly 300 branches and 3,000 employees serving approximately 1.3 million customers [7] - The bank combines various financial services, including finance, insurance, telephony, and advanced technological services, supported by the financial strength of the CIC Group and its parent company, Crédit Mutuel Alliance Fédérale [7]

Core Viewpoint - VINCI is initiating a capital increase reserved for employees of its foreign subsidiaries as part of its international Group savings plan, with the process set to take place from May 26, 2025, to June 13, 2025 [1][4]. Group 1: Capital Increase Details - The Board of Directors has authorized a capital increase for employees in various countries including Germany, Australia, Brazil, and the United States, among others [2]. - The Chief Executive Officer confirmed the decisions regarding the capital increase and has the authority to set subscription dates and prices [3]. - The issue price for the new shares is set at €125.33, based on the volume-weighted average price over the preceding 20 trading sessions [5]. Group 2: Subscription and Shareholder Rights - The maximum number of new shares issued will not exceed 1.5% of the authorized share capital at the time of the Board's decision [6]. - Employees will subscribe to the new shares through the "Castor International Relais 2025" FCPE, with some exceptions for direct subscriptions in specific countries [7]. - Subscribed shares will be subject to a three-year lock-up period, with dividend rights commencing from January 1, 2025 [8][10].

Core Viewpoint - Tonner Drones is enhancing its board with the appointment of two new directors, Fabrice Augereau and Arnoud Jullens, to support the company's next phase of turnaround and growth [2][7]. Group 1: New Board Members - Fabrice Augereau, an experienced engineer with a background in drone, robotics, and AI sectors, has previously collaborated with Tonner Drones on the Countbot project and is expected to bring valuable technical expertise to the board [3][7]. - Arnoud Jullens, who has extensive experience in guiding start-ups and scale-ups, is the CEO of Docklab and has a strong network in the business community, which Tonner Drones believes will contribute to its future growth [4][7]. Group 2: Company Developments - The restructuring and turnaround of Tonner Drones have been successfully completed, leading to the end of David Cloetingh's term as a director, with Olaf Graeff remaining on the board [5][7]. - The Annual General Meeting (AGM) is scheduled for June 19, 2025, where shareholders are encouraged to participate and vote to meet the quorum [6]. Group 3: Company Strategy - Tonner Drones focuses on developing technologies for the logistics sector and holds stakes in promising French drone manufacturers, aiming to increase the value of these investments through active asset management [8]. - The company plans to retain R&D for its products in France while not owning a factory, and it seeks to generate additional revenues through royalties from its patents [8].

This announcement contains information on transactions of the acquisition of own shares of AB Artea bankas (the Bank) carried during the period specified below under the Bank's own share buy-back programme announced on 30 April 2025.  The period during which the acquisition of the Bank's own shares under the programme was carried out – 05.05.2025 – 23.05.2025. <span lang="EN-US" style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin; mso-ansi-language: ...

AB KN Energies (hereinafter – KN, the Company) announces the unaudited consolidated (hereinafter – the Group) and separate financial results for the 3 months ended 31 March 2025. Key financial indicators for the 1- 3 months of 2025: EUR millionsGroupCompany 1-3 months of 20251-3 months of 20241-3 months of 20251-3 months of 2024Revenue25.324.4<td style="width:121.8px;;vertical-align: middle; text-align: left; pa ...